FDA Senior Advisor For Science Schwetz Named Acting Deputy Commissioner
This article was originally published in The Gray Sheet
Executive Summary
FDA Senior Advisor for Science Bernard Schwetz, PhD, will serve as acting deputy commissioner as the agency searches for a permanent appointee for the office vacated by Michael Friedman, MD.
You may also be interested in...
FDA Chief Scientist Schwetz May Have Larger Role Under Henney
FDA Interim Chief Scientist and National Center for Toxicology Research Director Bernard Schwetz, PhD, may be in line for a more prominent role at FDA under Commissioner Jane Henney.
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.